ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

16.42
Delayed Data
As of Aug 05
 +0.80 / +5.12%
Today’s Change
12.24
Today|||52-Week Range
28.06
-29.65%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$2.7B

Company Description

ACADIA Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on the development and commercialization of medicines to address unmet medical needs in central nervous system, or CNS, disorders. The firm's products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.

Contact Information

ACADIA Pharmaceuticals, Inc.
12830 El Camino Real
San Diego California 92130-3331
P:(858) 558-2871
Investor Relations:
(858) 261-2771

Employees

Shareholders

Other institutional57.05%
Mutual fund holders33.92%
Individual stakeholders32.45%

Top Executives

Stephen R. DavisChief Executive Officer & Director
Srdjan R. StankovicPresident
Brendan P. TeehanChief Operating Officer, EVP & Head-Commercial
Mark C. SchneyerChief Financial Officer & Executive Vice President
Bob MischlerSenior VP-Strategy & Technology Operations